Effect of phthalocyanine oral and nasal antiseptic solutions on the infectivity of SARS-CoV-2 in patients with COVID-19: a randomized controlled trial
GMS German Medical Science · 23.06.2023 · 21 (Doc07) · Doc07
DOI: 10.3205/000321 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift GMS German Medical Science, erschienen am 23.06.2023. Verfasst von Andréa Name Colado Simão und 12 weiteren Autor:innen. Beteiligte Einrichtung: Research Laboratory in Applied Immunology, State University of Londrina, Brazil. Hauptthemen laut MEDLINE: COVID-19, Anti-Infective Agents, Local. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
In individuals with coronavirus disease (COVID-19), the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load (VL) plays an important role in infectivity.
Objectives
This study aimed to evaluate the reduction in the VL and infectivity induced by phthalocyanine mouthwash and nasal spray in patients with COVID-19.
Methods
Patients with mild COVID-19 were recruited to participate in a triple-blinded randomized controlled trial. Participants were assigned to one of three groups: Group 1, non-active mouthwash and saline nasal spray (SNS); Group 2, phthalocyanine mouthwash and SNS; and Group 3 phthalocyanine mouthwash and phthalocyanine nasal spray. VL was assessed in nasopharyngeal and oropharyngeal swabs collected at the time of clinical diagnosis at baseline as well as 24 and 72 hours after starting the rinsing protocols.
Findings
Forty-six participants were included in the analysis: 15, 16, and 15 in Groups 1, 2, and 3, respectively. After 72 hours, the reduction in VL was significantly higher in Group 3 (mean cycle threshold (Ct) decrease: 11.21) than in Group 1 (mean Ct decrease: 5.53). Additionally, only the mean VL in Group 3 was reduced to a non-contagious level after 72 hours. Main conclusions: Use of phthalocyanine mouthwash and nasal spray is effective at reducing SARS-CoV-2 infectivity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Laboratory in Applied Immunology, State University of Londrina, Brazil.
- Department of Pharmaceutical Sciences, State University of Londrina, Brazil.
- Department of Surgery, Stomatology, Pathology and Radiology, Bauru School of Dentistry, University of São Paulo, Bauru, Brazil.
- TRIALS - Oral Health & Technologies, Bauru, Brazil.
Zitieren
APA
Colado Simão, A. N., Perugini Stadtlober, N., Stinghen Garcia Lonni, A. A., Venâncio, L. M., Lerner Trigo, G., de Souza Cassela, P. L. C., Mastellini Sanches Silva, T., De Fátima Oliveira Hirth Ruiz, M., Batisti Lozovoy, M. A., Tano, Z. N., da Fonseca Orcina, B., Vieira Vilhena, F., & da Silva Santos, P. S. (2023). Effect of phthalocyanine oral and nasal antiseptic solutions on the infectivity of SARS-CoV-2 in patients with COVID-19: a randomized controlled trial. GMS German Medical Science, 21(Doc07), Doc07. https://doi.org/10.3205/000321
Vancouver
Colado Simão AN, Perugini Stadtlober N, Stinghen Garcia Lonni AA, Venâncio LM, Lerner Trigo G, de Souza Cassela PLC, et al. Effect of phthalocyanine oral and nasal antiseptic solutions on the infectivity of SARS-CoV-2 in patients with COVID-19: a randomized controlled trial. GMS German Medical Science. 2023;21(Doc07):Doc07. doi:10.3205/000321
BibTeX
@article{ColadoSimo2023,
author = {Colado Simão, Andréa Name and Perugini Stadtlober, Nicole and Stinghen Garcia Lonni, Audrey Alesandra and Venâncio, Luiza Mara and Lerner Trigo, Guilherme and de Souza Cassela, Pedro Luis Candido and Mastellini Sanches Silva, Thais and De Fátima Oliveira Hirth Ruiz, Maria and Batisti Lozovoy, Marcell Alysson and Tano, Zuleica Naomi and da Fonseca Orcina, Bernardo and Vieira Vilhena, Fabiano and da Silva Santos, Paulo Sérgio},
title = {Effect of phthalocyanine oral and nasal antiseptic solutions on the infectivity of SARS-CoV-2 in patients with COVID-19: a randomized controlled trial},
journal = {GMS German Medical Science},
year = {2023},
volume = {21},
number = {Doc07},
pages = {Doc07},
doi = {10.3205/000321}
}
EUVIMED